Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Warby Parker Inc.NYSE: WRBY

Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026

Stock-based compensation growth accelerates

Q2 FY2026 stock-based compensation of $9.9M rose 11.3% year over year, ahead of the -14.9% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 13.1% from the prior quarter. Over 3 fiscal years it compounded at -29.4% a year.

Context

  • Stock-based compensation amounted to 4.0% of revenue in FY2025, down 2.2 pp from a year earlier.
  • Stock-based compensation increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +11.3% holds above the trailing-twelve-month pace of -14.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$9.9M-13.1% QoQ
Last fiscal yearDec 2025
$34.54M-27.0% YoY
LTMJun 2026
$34.6M-14.9% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.3%——
1 year-27.0%——
3-year CAGR-29.4%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
34.54M USD
Year-over-year change
-27.0%
4-year CAGR
-24.7%

Stock-Based Compensation vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 stock-based compensation of $34.6M is the 3rd largest of the 10 companies compared; the peer median is $22.73M.
  • Its year-over-year change of -14.9% is the 5th highest of 10, against a peer median of -17.5%.
  • Stock-based compensation amounts to 3.8% of revenue for WRBY, versus a peer median of 1.4%.
WRBY Competitors Peer median
Stock-Based Compensation for WRBY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$149M +12.9%+19.7%1.4%
ICUIICU Medical, Inc.LTM Jun 2026$41.12M -19.2%+15.7%1.9%
WRBYWarby Parker Inc.LTM Jun 2026$34.6M -14.9%-29.4%3.8%
QDELQuidelOrtho CorporationLTM Mar 2026$34.2M -23.5%-1.8%1.3%
HAEHaemonetics CorporationLTM Jun 2026$33.83M +8.0%+9.8%2.5%
ITGRInteger Holdings CorporationLTM Jul 2026$22.73M -7.9%+3.4%1.2%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$16M -57.9%-17.6%0.4%
BEAMBeam Therapeutics Inc.LTM Jun 2026$12.73M -111.5%+3.8%8.2%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$5.93M -7.1%—0.3%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$5.78M -17.5%+23.3%2.3%
Peer median (excluding WRBY) $22.73M-17.5%+6.8%1.4%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
Deferred Income Tax00000
Stock-Based Compensation107.15M98.03M70.51M47.29M34.54M
Change in Working Capital(24.5M)(14.55M)5.81M19.26M17.55M
Accounts Receivables(392K)(451K)(345K)(169K)(1.34M)
Inventory(18.62M)(11.79M)6.61M9.89M7.83M
Accounts Payables(11.11M)(7.94M)1.63M689K8.5M
Other Working Capital5.63M5.64M(2.09M)8.85M2.55M
Other Non-Cash Items7.76M5.42M9.32M6.72M6.78M
Operating Cash Flow(31.99M)10.37M60.99M98.74M110.79M
Capital Expenditures(48.51M)(60.18M)(53.67M)(64.03M)(67.05M)
Acquisitions (Net)00000
Purchases of Investments00(1M)(2M)0
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(48.51M)(60.18M)(54.67M)(66.03M)(67.05M)
Debt Repayment31.61M91K000
Common Stock Issued20.04M3.2M2.87M4.63M2.36M
Common Stock Repurchased(8.09M)0000
Dividends Paid00000
Other Financing Activities(20.56M)00333K(14.36M)
Financing Cash Flow23M3.29M2.87M4.96M(12M)
Effect of Forex Changes(161K)(1.31M)(882K)(406K)457K
Net Change in Cash(57.67M)(47.83M)8.31M37.27M32.2M
Free Cash Flow(80.51M)(49.81M)7.32M34.71M43.74M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.